Condensed Consolidated Interim Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 63,543	$ 64,365
Accounts receivable, net	28,992	18,223
Prepaid expenses	2,605	6,030
Other current assets	888	1,060
Total current assets	96,028	89,678
Property and equipment, net	15,423	13,051
Other assets	4,151	3,356
Total assets	115,602	106,085
Current liabilities:
Accounts payable	1,185	2,528
Accrued expenses and other current liabilities	10,804	5,578
Total current liabilities	11,989	8,106
Other liabilities	443	538
Total liabilities	12,432	8,644
Stockholders' Equity:
Additional paid-in capital	241,045	226,717
Accumulated deficit	(179,357)	(171,209)
Accumulated other comprehensive loss	(672)	(325)
Total stockholders' equity attributable to Enfusion, Inc.	61,129	55,296
Non-controlling interests	42,041	42,145
Total stockholders' equity	103,170	97,441
Total liabilities and stockholders' equity	115,602	106,085
Common Class A
Stockholders' Equity:
Common stock	67	66
Common Class B
Stockholders' Equity:
Common stock	$ 46	$ 47